Pathstone Holdings’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-9,597
Closed -$438K – 2229
2025
Q4
$438K Sell
9,597
-124
-1% -$5.52K ﹤0.01% 1797
2025
Q3
$412K Buy
+9,721
New +$366K ﹤0.01% 1866
2025
Q1
– Sell
-8,605
Closed -$246K – 2249
2024
Q4
$246K Sell
8,605
-995
-10% -$27.6K ﹤0.01% 2061
2024
Q3
$256K Sell
9,600
-22
-0.2% -$572 ﹤0.01% 2057
2024
Q2
$247K Buy
9,622
+22
+0.2% +$493 ﹤0.01% 2041
2024
Q1
$203K Buy
+9,600
New +$179K ﹤0.01% 2139

Other funds holding AORT

Pathstone Holdings's AORT Position: Q1 2026 in Review

Pathstone Holdings sold out of Artivion (AORT) in Q1 2026, closing a stake of 9,597 shares — an estimated $438K sold.

Pathstone Holdings first reported a position in AORT in Q1 2024 and held it in 6 quarters. The position peaked at $438K in Q4 2025. 239 funds tracked by Wall St. Rank hold AORT as of Q1 2026.

  • Pathstone Holdings reported no remaining Artivion position as of Q1 2026 after selling out during the quarter.
  • Pathstone Holdings sold 9,597 Artivion shares in Q1 2026, an estimated $438K.
  • Pathstone Holdings first reported a position in Artivion in Q1 2024 and held it in 6 quarters.
  • Pathstone Holdings's Artivion position peaked at $438K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Artivion as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.